Mesoblast Ltd ADR (NASDAQ:MESO) currently has a daily average trading volume of 2.14M but it saw 1871753 shares traded in last market. With a market cap of 720.48M USD, the company’s current market price of $6.32 came falling about -4.10 while comparing to the previous closing price of $6.59. In past 52 weeks, the stock remained buoying in the range of price level as high as $10.24 and as low as $1.61.
Taking a look at 20-day trading activity of Mesoblast Ltd ADR (MESO) gives us an average price of $3.20, while its current price level is -38.28% below from 52-week high level whereas it is 292.55% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $2.43 while that of 200 days or SMA-200 reads an average of $3.48. A closer look into the stock’s movement over the week reveals that its volatility is standing at 22.27% during that period while stretching the period over a month that decreases to 13.98%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 82.02 which implies that the stock is in overbought territory.
Over the week, MESO’s stock price is moving 60.81% up while it is 208.29% when we observe its performance for the past one month. Year-to-date it is 187.27% up and over the past year, the stock is showing an upside performance of 2.60%.
The latest quarterly earnings report issued by the company was for quarter ended 6/29/2023, when its quarterly earnings per share (EPS) of -$0.28 beat the consensus estimate of -$0.31 for the same. For MESO, analysts are forecasting an EPS-growth rate of 35.10% for current year and estimate for EPS growth in next year is -8.30%.
Currently, Mesoblast Ltd ADR’s total number of outstanding shares is 85.82M with 0.00% of that held by the insiders while 0.73% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -13.22% and return on equity (ROE) at -16.40%. Stock’s beta reads 3.56. Stock has a price to book (P/B) ratio of 1.26 while price to sale or P/S ratio amounts to 93.45. Its return on asset (ROA) is -11.54% on average.
